193 related articles for article (PubMed ID: 7659771)
1. Seroquel (ICI 204 636), a putative "atypical" antipsychotic, in schizophrenia with positive symptomatology: results of an open clinical trial and changes of neuroendocrinological and EEG parameters.
Wetzel H; Szegedi A; Hain C; Wiesner J; Schlegel S; Benkert O
Psychopharmacology (Berl); 1995 May; 119(2):231-8. PubMed ID: 7659771
[TBL] [Abstract][Full Text] [Related]
2. Quetiapine in patients with schizophrenia. A high- and low-dose double-blind comparison with placebo. Seroquel Study Group.
Small JG; Hirsch SR; Arvanitis LA; Miller BG; Link CG
Arch Gen Psychiatry; 1997 Jun; 54(6):549-57. PubMed ID: 9193196
[TBL] [Abstract][Full Text] [Related]
3. ICI 204,636, an atypical antipsychotic: efficacy and safety in a multicenter, placebo-controlled trial in patients with schizophrenia. U.S. SEROQUEL Study Group.
Borison RL; Arvanitis LA; Miller BG
J Clin Psychopharmacol; 1996 Apr; 16(2):158-69. PubMed ID: 8690831
[TBL] [Abstract][Full Text] [Related]
4. Multiple fixed doses of "Seroquel" (quetiapine) in patients with acute exacerbation of schizophrenia: a comparison with haloperidol and placebo. The Seroquel Trial 13 Study Group.
Arvanitis LA; Miller BG
Biol Psychiatry; 1997 Aug; 42(4):233-46. PubMed ID: 9270900
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of quetiapine for the treatment of schizophrenia: a combined analysis of three placebo-controlled trials.
Buckley PF
Curr Med Res Opin; 2004 Sep; 20(9):1357-63. PubMed ID: 15383183
[TBL] [Abstract][Full Text] [Related]
6. A multicentre, double-blind, randomized comparison of quetiapine (ICI 204,636, 'Seroquel') and haloperidol in schizophrenia.
Copolov DL; Link CG; Kowalcyk B
Psychol Med; 2000 Jan; 30(1):95-105. PubMed ID: 10722180
[TBL] [Abstract][Full Text] [Related]
7. A comparison of the effects of quetiapine ('seroquel') and haloperidol in schizophrenic patients with a history of and a demonstrated, partial response to conventional antipsychotic treatment. PRIZE Study Group.
Emsley RA; Raniwalla J; Bailey PJ; Jones AM
Int Clin Psychopharmacol; 2000 May; 15(3):121-31. PubMed ID: 10870870
[TBL] [Abstract][Full Text] [Related]
8. Quetiapine : A Review of its Use in Schizophrenia.
Gunasekara NS; Spencer CM
CNS Drugs; 1998 Apr; 9(4):325-40. PubMed ID: 27521016
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of quetiapine in adolescents with schizophrenia investigated in a 6-week, double-blind, placebo-controlled trial.
Findling RL; McKenna K; Earley WR; Stankowski J; Pathak S
J Child Adolesc Psychopharmacol; 2012 Oct; 22(5):327-42. PubMed ID: 23083020
[TBL] [Abstract][Full Text] [Related]
10. ICI 204,636, a novel, atypical antipsychotic: early indication of safety and efficacy in patients with chronic and subchronic schizophrenia.
Fabre LF; Arvanitis L; Pultz J; Jones VM; Malick JB; Slotnick VB
Clin Ther; 1995; 17(3):366-78. PubMed ID: 7585841
[TBL] [Abstract][Full Text] [Related]
11. A comparison of bd and tid dose regimens of quetiapine (Seroquel) in the treatment of schizophrenia.
King DJ; Link CG; Kowalcyk B
Psychopharmacology (Berl); 1998 May; 137(2):139-46. PubMed ID: 9630000
[TBL] [Abstract][Full Text] [Related]
12. Plasma prolactin in schizophrenia subjects treated with Seroquel (ICI 204,636).
Hamner MB; Arvanitis LA; Miller BG; Link CG; Hong WW
Psychopharmacol Bull; 1996; 32(1):107-10. PubMed ID: 8927658
[TBL] [Abstract][Full Text] [Related]
13. Medical-claims databases in the design of a health-outcomes comparison of quetiapine ('Seroquel') and usual-care antipsychotic medication.
Hong WW; Rak IW; Ciuryla VT; Wilson AM; Kylstra JW; Meltzer HY; Carpenter WT; Lehman A; Arvanitis LA
Schizophr Res; 1998 Jun; 32(1):51-8. PubMed ID: 9690334
[TBL] [Abstract][Full Text] [Related]
14. Prolactin, subjective well-being and sexual dysfunction: an open label observational study comparing quetiapine with risperidone.
Westheide J; Cvetanovska G; Albrecht C; Bliesener N; Cooper-Mahkorn D; Creutz C; Hornung WP; Klingmüller D; Lemke MR; Maier W; Schubert M; Sträter B; Kühn KU
J Sex Med; 2008 Dec; 5(12):2816-26. PubMed ID: 18466271
[TBL] [Abstract][Full Text] [Related]
15. [Seroquel in a resistant schizophrenic with negative and positive symptoms].
Reznik I; Benatov R; Sirota P
Harefuah; 1996 May; 130(10):675-7, 727. PubMed ID: 8794656
[TBL] [Abstract][Full Text] [Related]
16. Impact of a switch from typical to atypical antipsychotic drugs on quality of life and gonadal hormones in male patients with schizophrenia.
Kaneda Y; Kawamura I; Fujii A; Ohmori T
Neuro Endocrinol Lett; 2004; 25(1-2):135-40. PubMed ID: 15159697
[TBL] [Abstract][Full Text] [Related]
17. Treatment of depressive mood in schizophrenia with the atypical antipsychotic quetiapine.
Khouzam HR
Depress Anxiety; 2000; 11(2):80-2. PubMed ID: 10812533
[TBL] [Abstract][Full Text] [Related]
18. Effects of risperidone and quetiapine on cognition in patients with schizophrenia and predominantly negative symptoms.
Riedel M; Spellmann I; Strassnig M; Douhet A; Dehning S; Opgen-Rhein M; Valdevit R; Engel RR; Kleindienst N; Müller N; Möller HJ
Eur Arch Psychiatry Clin Neurosci; 2007 Sep; 257(6):360-70. PubMed ID: 17629731
[TBL] [Abstract][Full Text] [Related]
19. Quetiapine has equivalent efficacy and superior tolerability to risperidone in the treatment of schizophrenia with predominantly negative symptoms.
Riedel M; Müller N; Strassnig M; Spellmann I; Engel RR; Musil R; Dehning S; Douhet A; Schwarz MJ; Möller HJ
Eur Arch Psychiatry Clin Neurosci; 2005 Dec; 255(6):432-7. PubMed ID: 16267634
[TBL] [Abstract][Full Text] [Related]
20. Seroquel: biochemical profile of a potential atypical antipsychotic.
Saller CF; Salama AI
Psychopharmacology (Berl); 1993; 112(2-3):285-92. PubMed ID: 7871032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
